Novozymes invests in Nebraska
- Publisher
- Elsevier Science
- Year
- 2009
- Weight
- 57 KB
- Volume
- 2009
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In view of the economic environment, Novozymes considers its current 2009 growth outlook satisfactory. The slowdown in 4Q 2008 is not considered a reliable indicator of 2009 full-year performance. Sales growth is forecast at 8-13% (in terms of DKR), and operating profit is expected to grow by 10-15%
commercialisation of next-generation ethanol. Verenium is one of two companies that were selected for this round of DOE grants and will utilize the funds to support ongoing activities at its 1.4 M gallon/y demonstrationscale facility in Jennings, LA. The grant was announced by
the Catalysts Division employed 2271 people worldwide. This represented an increase in its workforce of 443, of which 323 resulted solely from the majority interest acquired in Alvigo as, Tallinn, Estonia, a manufacturer of synthesis gas catalysts which has meanwhile been renamed to SΓΌd-Chemie Alvig
NEW PLANTS ## Celtic Catalysts opens UK pilot plant Chemical development firm Celtic Catalysts has inaugurated a new pilotscale production plant at the former ICI site in Redcar, NE England. The plant will house Celtic Catalysts' large-scale reactors that will allow the production of various prod